Compounding This Week Newsletter from www.CompoundingToday.com
Brought to you by the International Journal of Pharmaceutical CompoundingHeader
June 8, 2012 Volume 9, Issue 23
  In This Issue
 
  Classifieds

To place a classified advertisement please contact: Lauren Bernick lbernick@ijpc.com or 405-513-4236

 
  About
  CompoundingToday
 
  Free Resources
 
  Subscriber
  Resources
 
Renew your subscription for 2 year and recieve a free binder
Testing for Endotoxins?  For fully USP BET compliant endotoxin tests, use ACC's New Pyros Kinetix Flex!
 
Loyd V. Allen, Jr., Ph.d., R.Ph  Letter from the Editor
Loyd V. Allen, Jr., Ph.D., R.Ph.

Editorial: The Idea Light Bulb!

When reading a comic or watching a cartoon, sometimes the "actor" will come up with an idea and a "light bulb" is featured above their head. In the future, will this be a light bulb with or without mercury?

It's interesting that the new light bulbs we are being forced to buy for household use contain mercury, whereas the older bulbs contained a tungsten filament inside a vacuum within a glass globe. When they burnt out, they were simply destroyed with no harmful gases, etc.

While reading one of the airline magazines this week, I saw an ad for a new video projector with LED lights that list the advantage, "these new projector bulbs contain NO mercury"! One is left wondering, "To Hg or not to Hg...that is the question?" I don't know of very many individuals that like the new household light bulbs.

These new light bulbs do not work well with motion sensors because they are slow to respond, and they�

�are slow to come to full power.
�are more expensive.
�are difficult to discard or dispose of.
�do not last nearly as long as advertised.
�are shaped funny.
�do not always fit into current lamps, lamp globes, etc.

It seems like the new light bulbs are in the same category as the one-gallon per flush toilets!


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief

 
News

Drug Recalls Occur by FDA about Every Month
The FDA recalls potentially harmful drugs about once every month, but they could be doing a better job of letting doctors and patients know about them, according to a new study. The study showed that over an eight-year span, the FDA failed to send notifications for one in five of the most serious recalls through its two electronic systems used to alert doctors and the public. These Class I recalls, according to the FDA, are issued for drugs that, if taken, have the potential to cause "serious adverse health consequences or death."
http://www.reuters.com/article/2012/06/04/us-drug-recalls-idUSBRE8530ZK20120604

Expired Drugs Often Found in Physicians' Samples
Experts say physicians do not track the dates on their samples, and they should either monitor samples carefully or stop accepting them. According to a recent study, one in seven drug packages stored in physicians' pharmaceutical sample closets has expired, and an estimated $2.2 billion worth of drug samples go to waste each year.

Although it is unlikely that the expired medications would pose much of a danger to patients, the drugs do lose potency with time, and dispensing ineffective medication could lead to future mistakes in care, the study authors said.

Clinic office closets must be kept organized, regularly checked for expired medicines, and comply with drug recalls. There is a wide variation in the organization of the closets with some of them looking like the Hogwarts castle after it was destroyed, with books lying everywhere-a total mess, according to the report.
http://www.ama-assn.org/amednews/2012/06/04/prsc0605.htm#top

FDA: Teething Pain Remedies Dangerous
The FDA has warned that rubbing topical anesthetics such as Anbesol or Orajel on the throbbing gums of a teething baby can lead to methemoglobinemia and—in extreme cases—death. These OTC products contain benzocaine, and that is the source of the FDA's concern. The risk appears greatest among children less than 2 years old, the age range at which most children experience teething pain.
http://www.medpagetoday.com/Pediatrics/GeneralPediatrics/33006

Lawmakers Moving To Close Legal Loopholes on 'Bath Salts'
Bath salts, which first emerged in Europe, have gained wider attention in the U.S. after a man suspected of being on the drug at the time attacked and consumed the flesh of a homeless man in Miami. The designer drugs are the subject of a federal bill as lawmakers and enforcers scramble to close loopholes in regulating an evolving substance. The provision would outlaw synthetic marijuana alongside MDPV (methylenedioxypyrovalerone), mephedrone, and possibly, methylone—the main stimulants found in the drugs. Even though drugs' active compounds were placed on an emergency ban by the DEA, they can still be found in convenience stores, smoke shops, and online where it is sold in packets or jars and often labeled as "not intended for human consumption."
http://blogs.wsj.com/health/2012/06/06/lawmakers-moving-to-close-legal-loopholes-on-bath-salts/

FDA to Let Women Try New Breast Drugs Earlier
A new FDA guidance document will allow drug companies to test their medications for a few months on women with highly aggressive breast cancers before they have surgery, instead of waiting until the drug has been proven first in gravely ill patients.

The aim of this therapy would be to cure the woman of breast cancer by moving a very promising drug into an early stage of the disease with a curative intent. This is a significant change from the current approach, in which promising drugs only are tested in earlier stage cancers after they have first proven to be safe and effective in advanced, metastatic cancer.
http://www.reuters.com/article/2012/06/03/us-cancer-trials-fda-idUSBRE85208720120603

FDA Approves the SoloHealth Station
SoloHealth has received approval from the FDA for its next-generation SoloHealth Station. This is an interactive, comprehensive health and wellness screening kiosk for consumers. The SoloHealth Station accommodates health screenings for vision, blood pressure, weight, and body mass index, a symptom checker as well as an overall health assessment free of charge.
http://www.pharmacynewsflash.com/opha/Story.nsp?story_id=173497329

 
IJPC Now on Facebook

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

 
Did You Know ...

�that you can still purchase standard light bulbs?

 
Compounding Tip of the Week
New Technology

Don't jump into new technology just because it is new...evaluate it first!

 
Looking Back

Spring has sprung,
The grass has riz,
Where last year's
Careless drivers is�
      Burma Shave

 
PCAB Accreditations

PCAB is proud to announce the accreditation of the following pharmacy:

Sheefa Pharmacy & Wellness Center, East Orange, New Jersey; Ashraf Latif, RPh, Owner; sheefapharmacy@gmail.com; Initial Accreditation for Nonsterile Compounding.

Please join us in our congratulations for this achievement.

 
18th Annual Compounders on Capitol Hill

June 23-26, 2012
JW Marriott on Pennsylvania Avenue
Washington, D.C.

Anticipation has been building for another successful Compounders on Capitol Hill (CCH) in Washington, D.C.! IACP Members, friends and colleagues will soon gather on behalf of their patients and practitioners to take several vital issues to the Hill in a continuing effort to Protect, Promote and Advance Pharmacy Compounding!

The ever-popular Hill Day State Breakfast and Briefing followed by Hill Appointments will take place during CCH on Tuesday, June 26, 2012. To help prepare our CCH attendees for this important event, IACP wanted to share some event details, including the three primary CCH 2012 Asks, briefing documents IACP has developed to help Members communicate the issues to their respective congressional offices.

Please see the IACP site for full details.

Copyright 2012
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com
Reprints & Permissions: Reprints@ijpc.com